596 related articles for article (PubMed ID: 20716670)
1. Frequent deregulations in the hedgehog signaling network and cross-talks with the epidermal growth factor receptor pathway involved in cancer progression and targeted therapies.
Mimeault M; Batra SK
Pharmacol Rev; 2010 Sep; 62(3):497-524. PubMed ID: 20716670
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor receptor signaling synergizes with Hedgehog/GLI in oncogenic transformation via activation of the MEK/ERK/JUN pathway.
Schnidar H; Eberl M; Klingler S; Mangelberger D; Kasper M; Hauser-Kronberger C; Regl G; Kroismayr R; Moriggl R; Sibilia M; Aberger F
Cancer Res; 2009 Feb; 69(4):1284-92. PubMed ID: 19190345
[TBL] [Abstract][Full Text] [Related]
3. Frequent gene products and molecular pathways altered in prostate cancer- and metastasis-initiating cells and their progenies and novel promising multitargeted therapies.
Mimeault M; Batra SK
Mol Med; 2011; 17(9-10):949-64. PubMed ID: 21607288
[TBL] [Abstract][Full Text] [Related]
4. New advances on critical implications of tumor- and metastasis-initiating cells in cancer progression, treatment resistance and disease recurrence.
Mimeault M; Batra SK
Histol Histopathol; 2010 Aug; 25(8):1057-73. PubMed ID: 20552555
[TBL] [Abstract][Full Text] [Related]
5. Complex oncogenic signaling networks regulate brain tumor-initiating cells and their progenies: pivotal roles of wild-type EGFR, EGFRvIII mutant and hedgehog cascades and novel multitargeted therapies.
Mimeault M; Batra SK
Brain Pathol; 2011 Sep; 21(5):479-500. PubMed ID: 21615592
[TBL] [Abstract][Full Text] [Related]
6. Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies.
Mimeault M; Batra SK
Mol Aspects Med; 2014 Oct; 39():3-32. PubMed ID: 23994756
[TBL] [Abstract][Full Text] [Related]
7. Interplay of distinct growth factors during epithelial mesenchymal transition of cancer progenitor cells and molecular targeting as novel cancer therapies.
Mimeault M; Batra SK
Ann Oncol; 2007 Oct; 18(10):1605-19. PubMed ID: 17355951
[TBL] [Abstract][Full Text] [Related]
8. Recent progress on normal and malignant pancreatic stem/progenitor cell research: therapeutic implications for the treatment of type 1 or 2 diabetes mellitus and aggressive pancreatic cancer.
Mimeault M; Batra SK
Gut; 2008 Oct; 57(10):1456-68. PubMed ID: 18791122
[TBL] [Abstract][Full Text] [Related]
9. Hedgehog-EGFR cooperation response genes determine the oncogenic phenotype of basal cell carcinoma and tumour-initiating pancreatic cancer cells.
Eberl M; Klingler S; Mangelberger D; Loipetzberger A; Damhofer H; Zoidl K; Schnidar H; Hache H; Bauer HC; Solca F; Hauser-Kronberger C; Ermilov AN; Verhaegen ME; Bichakjian CK; Dlugosz AA; Nietfeld W; Sibilia M; Lehrach H; Wierling C; Aberger F
EMBO Mol Med; 2012 Mar; 4(3):218-33. PubMed ID: 22294553
[TBL] [Abstract][Full Text] [Related]
10. Hedgehog signaling pathway as a therapeutic target in various types of cancer.
Onishi H; Katano M
Cancer Sci; 2011 Oct; 102(10):1756-60. PubMed ID: 21679342
[TBL] [Abstract][Full Text] [Related]
11. Crosstalk between hedgehog and other signaling pathways as a basis for combination therapies in cancer.
Brechbiel J; Miller-Moslin K; Adjei AA
Cancer Treat Rev; 2014 Jul; 40(6):750-9. PubMed ID: 24613036
[TBL] [Abstract][Full Text] [Related]
12. HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity.
Clement V; Sanchez P; de Tribolet N; Radovanovic I; Ruiz i Altaba A
Curr Biol; 2007 Jan; 17(2):165-72. PubMed ID: 17196391
[TBL] [Abstract][Full Text] [Related]
13. The Hedgehog pathway: role in cell differentiation, polarity and proliferation.
Jia Y; Wang Y; Xie J
Arch Toxicol; 2015 Feb; 89(2):179-91. PubMed ID: 25559776
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers.
Mimeault M; Hauke R; Mehta PP; Batra SK
J Cell Mol Med; 2007; 11(5):981-1011. PubMed ID: 17979879
[TBL] [Abstract][Full Text] [Related]
15. Hedgehog signaling and the Gli code in stem cells, cancer, and metastases.
Ruiz i Altaba A
Sci Signal; 2011 Nov; 4(200):pt9. PubMed ID: 22114144
[TBL] [Abstract][Full Text] [Related]
16. The intrahepatic signalling niche of hedgehog is defined by primary cilia positive cells during chronic liver injury.
Grzelak CA; Martelotto LG; Sigglekow ND; Patkunanathan B; Ajami K; Calabro SR; Dwyer BJ; Tirnitz-Parker JE; Watkins DN; Warner FJ; Shackel NA; McCaughan GW
J Hepatol; 2014 Jan; 60(1):143-51. PubMed ID: 23978713
[TBL] [Abstract][Full Text] [Related]
17. Cooperative integration between HEDGEHOG-GLI signalling and other oncogenic pathways: implications for cancer therapy.
Pandolfi S; Stecca B
Expert Rev Mol Med; 2015 Feb; 17():e5. PubMed ID: 25660620
[TBL] [Abstract][Full Text] [Related]
18. Targeting GLI Transcription Factors in Cancer.
Didiasova M; Schaefer L; Wygrecka M
Molecules; 2018 Apr; 23(5):. PubMed ID: 29695137
[TBL] [Abstract][Full Text] [Related]
19. Hedgehog-GLI signaling drives self-renewal and tumorigenicity of human melanoma-initiating cells.
Santini R; Vinci MC; Pandolfi S; Penachioni JY; Montagnani V; Olivito B; Gattai R; Pimpinelli N; Gerlini G; Borgognoni L; Stecca B
Stem Cells; 2012 Sep; 30(9):1808-18. PubMed ID: 22730244
[TBL] [Abstract][Full Text] [Related]
20. Novel therapies against aggressive and recurrent epithelial cancers by molecular targeting tumor- and metastasis-initiating cells and their progenies.
Mimeault M; Batra SK
Anticancer Agents Med Chem; 2010 Feb; 10(2):137-51. PubMed ID: 20184544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
